Surgical site infections present a formidable challenge following neurosurgical procedures. When post-craniotomy infection occurs, neurosurgeons face a difficult decision regarding bone flap management. Recent multicenter evidence highlights the significant therapeutic benefits of bone flap explantation over immediate salvage. This landmark study provides critical insights for practicing neurosurgeons and multidisciplinary care teams. Specifically, researchers evaluated recurrence patterns among matched cohorts undergoing different surgical strategies. Consequently, these findings offer actionable clarity for standardizing postoperative wound management protocols.

Clinical Challenge: Managing Infection After Craniotomy

Postoperative surgical site infection after elective craniotomy represents a serious complication in neurosurgical practice. This adverse event leads to prolonged hospitalization, increased financial burden, and significant patient morbidity. When managing post-craniotomy infection, surgeons face a challenging clinical dilemma regarding the cranial bone. Preserving the original bone flap offers clear reconstructive advantages. Retaining the native bone avoids secondary reconstructive surgeries, preserves cranial contour, and protects underlying brain parenchyma. However, contaminated bone tissue frequently harbors virulent bacterial biofilms. These microbial communities adhere strongly to the porous bone matrix, creating a shielded barrier against circulating antibiotics and host immune cells. Consequently, retained bone flaps often act as persistent infectious reservoirs that provoke secondary relapses. Conversely, performing bone removal leaves an unprotected cranial defect. This approach exposes patients to complications such as aesthetic deformities and risks associated with staged cranioplasty. Due to these competing priorities, clinical approaches historically vary widely across surgical centers globally.

Evidence on Bone Flap Explantation Versus Salvage

A rigorous multicenter propensity-matched cohort study provides definitive evidence on this long-standing clinical question. The study analyzed outcomes from 160 adult patients who underwent revision surgery for surgical site infection following elective craniotomy. To eliminate confounding baseline differences, researchers matched 80 patients undergoing bone flap explantation with 80 patients undergoing bone flap reimplantation based on age and FRAIL score. The primary clinical endpoint evaluated the rate of recurrent surgical site infection during follow-up. The study uncovered striking differences between the two surgical cohorts. Patients treated with bone flap explantation experienced a recurrent infection rate of only 18 percent. In contrast, patients in the reimplantation cohort suffered a recurrent infection rate of 49 percent, demonstrating a statistically significant reduction in treatment failure. Remarkably, patients in the explantation cohort presented with signs of more extensive baseline infections prior to revision. Despite having more severe underlying infection, removing the bone flap provided definitive microbiological control and drastically reduced recurrent disease.

Risk Predictors and Recurrence Dynamics

Multivariable Cox regression analysis from the cohort study highlighted critical independent factors associated with infection recurrence. The depth and anatomical extent of the infectious process played a decisive role in patient prognosis. Specifically, infections strictly confined to the superficial subcutaneous tissue demonstrated significantly lower recurrence rates than deep subgaleal or epidural infections. Furthermore, consistent administration of perioperative antimicrobial therapy provided a substantial protective effect against microbial resurgence. The statistical model also demonstrated that shorter post-revision hospitalization correlated with decreased reinfection risks. Bacterial biofilms established on devitalized cortical bone represent a major barrier to medical cure. Pathogens such as Staphylococcus aureus produce dense extracellular matrices within bone canals that block therapeutic antibiotic concentrations. Therefore, surface debridement alone cannot reliably eradicate deep-seated microbial colonies. Complete removal of the colonized bone flap eliminates this protected bacterial nidus. By identifying high-risk anatomical features, clinicians can tailor surgical decision-making and avoid ineffective conservative retention strategies.

Hospital Stay and Healthcare Burden Considerations

Beyond microbiological eradication, the surgical strategy chosen during revision significantly influences hospital resource utilization and patient recovery. The multicenter study revealed that patients undergoing bone flap explantation experienced a shorter postoperative hospital stay of 7 days compared to 12 days for those undergoing reimplantation. Although bone explantation necessitates a future staged cranioplasty, avoiding acute infectious recurrences prevents repeated emergency hospitalizations. Patients experiencing recurrent infections often require multiple unplanned debridements, prolonged intravenous antimicrobial courses, and extended intensive monitoring. Consequently, initial bone removal reduces the overall clinical and economic burden associated with protracted infectious complications. Shortening the acute length of stay also diminishes the risk of secondary nosocomial infections and catheter-related adverse events. These findings show that definitive initial source control optimizes hospital bed turnover and reduces resource strain. Hospital administrators and clinical leaders must consider these economic and recovery benefits when evaluating the total cost profile of post-craniotomy infection management protocols.

Implications for Surgical Decision-Making in India

In Indian healthcare environments, managing neurosurgical site infections presents distinct challenges due to high antimicrobial resistance rates and socioeconomic factors. Multidrug-resistant pathogens, including resistant staphylococci and gram-negative bacteria, frequently complicate hospital-acquired surgical site infections. In such settings, attempting to salvage infected bone flaps carries an exceptionally high probability of therapeutic failure and chronic osteomyelitis. Moreover, repeated surgical revisions and prolonged hospital admissions generate devastating financial toxicity for self-paying patients. Adopting standardized neurosurgical protocols that favor bone flap explantation during initial revision provides a pragmatic, evidence-based solution. Removing the contaminated bone ensures rapid source control, shortens hospital stays, and mitigates the need for costly salvage interventions. Surgeons can subsequently plan elective cranioplasty using custom synthetic implants or preserved autologous bone once the surgical site is completely sterile. Combining aggressive surgical source control with culture-directed antimicrobial stewardship improves patient safety across tertiary care centers throughout India.

Frequently Asked Questions

Why does bone flap explantation reduce recurrent surgical site infection rates?

Bone flap explantation eliminates devitalized cranial bone that harbors persistent bacterial biofilms. Because systemic antibiotics cannot easily penetrate colonized bone matrix, retaining the bone creates a persistent bacterial reservoir. Removing the bone provides definitive source control, allowing antibiotics and host immunity to clear surrounding soft-tissue infection effectively.

What are the primary predictors of recurrent cranial surgical site infection?

Key predictors of recurrent infection include the depth of initial infection, perioperative antibiotic coverage, and length of postoperative stay. Infections extending beyond the subcutaneous space carry higher recurrence risks. Conversely, appropriate antibiotic therapy and definitive surgical source control substantially lower the probability of treatment failure.

Does bone flap explantation lead to longer overall hospitalization?

No, evidence demonstrates that bone flap explantation results in a shorter acute postoperative hospital stay compared to reimplantation. By preventing acute reinfection and repeated emergency revisions, explantation reduces initial inpatient duration from an average of twelve days down to seven days, streamlining recovery.

Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Lucia K et al. The role of bone flap explantation in the recurrence of surgical site infection after elective craniotomy: A multicenter propensity-matched cohort study. Neurosurg Rev. 2026 Jun 01. doi: 10.1007/s10143-026-04291-0. PMID: 42223499.

Delgado-López PD, et al. Preservation of bone flap after craniotomy infection. Neurocirugia (Astur). 2009;20(2):124-131.

Korinek AM, et al. Risk factors for neurosurgical site infections after craniotomy: a prospective multicenter study of 2944 patients. Neurosurgery. 2005;57(4):700-710.